[Federal Register Volume 63, Number 161 (Thursday, August 20, 1998)]
[Notices]
[Page 44630]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-22410]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting with be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Preclinical Evaluation of Intermediate Endpoints and their 
Modulation by Chemopreventive Agents.
    Date: September 14, 1998.
    Time: 3:00 PM to 5:30 PM.
    Agenda: To review and evaluate grant applications.
    Place: 6130 Executive Blvd. 6th Floor, Rockville, MD 20852.
    Contact Person: Lalita D. Palekar, Scientific Review 
Administrator, Special Review, Referral and Resources Branch, 
Division of Extramural Activities, National Cancer Institute, 
National Institutes of Health, 6130 Executive Boulevard EPN-622B, 
Rockville, MD 20892-7405, 301/496-7575.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 14, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-22410 Filed 8-19-98; 8:45 am]
BILLING CODE 4140-01-M